SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD. Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.79 CNY | +0.74% |
|
+3.98% | -10.78% |
Business Summary
Number of employees: 1,570
Sales per Business
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Other
41.8
%
| 965 | 40.4 % | 978 | 41.8 % | +1.35% |
Anti-tumor Drug
30.1
%
| 848 | 35.5 % | 704 | 30.1 % | -16.98% |
Traditional Chinese Medicine Cough Relief
12.5
%
| 219 | 9.2 % | 292 | 12.5 % | +33.77% |
Three High Chronic Disease Product
4.6
%
| 93 | 3.9 % | 107 | 4.6 % | +14.14% |
Skin External Antibacterial
3.8
%
| 101 | 4.2 % | 90 | 3.8 % | -10.82% |
Miao Medicine Muscle and Bone Strengthening
3.8
%
| 82 | 3.4 % | 89 | 3.8 % | +8.33% |
Classic Tonic Product
2.2
%
| 46 | 1.9 % | 50 | 2.2 % | +10.11% |
Magic Baby Medicine
1.3
%
| 35 | 1.5 % | 31 | 1.3 % | -12.32% |
Sales per region
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
China
100.0
%
| 2,389 | 100.0 % | 2,341 | 100.0 % | -2.00% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Bin Feng
CEO | Chief Executive Officer | 52 | 05-06-30 |
Ke Jing Wu
SEC | Corporate Secretary | 47 | 17-04-27 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shi Gui Chen
BRD | Director/Board Member | 61 | 20-06-28 |
Bin Feng
CEO | Chief Executive Officer | 52 | 05-06-30 |
Zhi Ting Zhang
BRD | Director/Board Member | 80 | 20-06-25 |
Tao Tao Zhang
CHM | Chairman | 43 | 14-06-25 |
Tao Wu
BRD | Director/Board Member | 52 | 13-10-15 |
Yu Bo Xia
CHM | Chairman | 52 | 14-06-25 |
Dan Xu
BRD | Director/Board Member | 53 | 14-06-25 |
Lan Hu
BRD | Director/Board Member | 55 | 07-06-21 |
Cong Yan Li
BRD | Director/Board Member | 58 | 20-06-28 |
Ke Jing Wu
SEC | Corporate Secretary | 47 | 17-04-27 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 54,751,650 | 54,751,650 ( 100.00 %) | 0 | 49.01 % |
| Stock B | 1 | 479,319,978 | 207,011,562 ( 43.19 %) | 0 |
Company contact information
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Room 613, Changfa Building 128, Weihai Road
200003, Shanghai
+
http://www.gzsq.com
Sector
Sales per Business
| 1st Jan change | Capi. | |
|---|---|---|
| -10.78% | 482M | |
| +33.16% | 700B | |
| -4.94% | 358B | |
| +18.96% | 330B | |
| +3.40% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.13% | 161B | |
| -1.82% | 157B |
- Stock Market
- Equities
- 600613 Stock
- Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.